Flinn, I. W., Jacobson, C., Nastoupil, L. J., Morschhauser, F., Davies, A. J., Buske, C., Corradini, P., Lopez-Guillermo, A., Reshef, R., Parameswaran, V., Sehgal, A., Tees, M., Lui, C., Xue, W., Beygi, S., Grechko, N., Bolsue, P., Giovanetti, A., To, C., & Nahas, M. (2023). P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA. HemaSphere, 7(S3), e6350662. https://doi.org/10.1097/01.hs9.0000971324.63506.62